Showing results (111-120 of 512) with videos related to

Sort By:
Pageof 52
Crohn'S & Colitis 360|August 8, 2026
Confirming the association of ulcerative colitis with interstitial lung disease: a retrospective analysis of comorbid disease, demographics, and healthcare utilizationSneh Parekh, Landen Shane Burstiner, Kaitlyn Romero, et al.
Crohn'S & Colitis 360|August 12, 2026
Evaluation of pharmacokinetic metrics and pharmacodynamic biomarkers associated with endoscopic healing in pediatric Crohn's disease patients treated with anti-tumor necrosis factor biologicsCourtney Bartel, Tomoyuki Mizuno, Rebekah Karns, et al.
Crohn'S & Colitis 360|August 14, 2026
Continued concomitant antibiotic or immunosuppression therapies reduce the risk of pouchitis among patients with ileal pouch-anal anastomosis and primary sclerosing cholangitisJohn P Haydek, Priscila Santiago, Joseph Carter Powers, et al.
Crohn'S & Colitis 360|July 28, 2026
Associations between fatigue, physical fitness, and physical activity in patients with inflammatory bowel diseaseKarlijn Demers, Bart C Bongers, Sander M J van Kuijk, et al.
Crohn'S & Colitis 360|July 28, 2026
One-year dynamics of clinical activity during biologics therapy in patients of ulcerative colitisYizhe Tie, Fengyuan Su, Jianwu Zhang, et al.
Crohn'S & Colitis 360|July 28, 2026
Remote monitoring to improve engagement for patients with inflammatory bowel disease: a randomized clinical trialShivan J Mehta, Phuoc Nguyen, Caitlin Brophy, et al.
Crohn'S & Colitis 360|September 19, 2026
Advanced therapy options, choice, access, and treatment empowerment for inflammatory bowel disease (ADVOCATE-IBD): a UK-wide semi-structured interview study exploring patient preferences around advanced therapy decisions in inflammatory bowel diseaseRonit Hardasani, Shellie Jean Radford, Mohammad Farhad Peerally
Crohn'S & Colitis 360|September 10, 2026
Colombian registry of inflammatory bowel disease in pediatricsFernando Sarmiento Quintero, Ana María Castañeda Figueroa, Diana Victoria Mora Quintero, et al.
Crohn'S & Colitis 360|October 23, 2026
A real-world study of healthcare resource utilization and costs in patients with Crohn's disease and ulcerative colitis initiating ustekinumab treatment via Johnson & Johnson's BIOADVANCE programLaura Targownik, Eneda Pone, Martin G Latour, et al.
Crohn'S & Colitis 360|February 4, 2025
Assessing the Impact of Interval Duration Between Ileal Pouch Creation and Loop Ileostomy Closure on the Development of Subsequent Inflammatory Pouch Conditions in Patients with Ulcerative ColitisMark Zemanek, Katherine Westbrook Cates, Joseph Carter Powers, et al.
Pageof 52